We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.99%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$52.3B
AUM Growth
-$3.99B
Cap. Flow
-$1.21B
Cap. Flow %
-2.32%
Top 10 Hldgs %
29.58%
Holding
1,740
New
31
Increased
388
Reduced
563
Closed
51

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Financials 14.62%
3 Healthcare 13.57%
4 Consumer Discretionary 9.97%
5 Communication Services 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HVT icon
1701
Haverty Furniture Companies
HVT
$418M
-19,087
Closed -$425K
IBRX icon
1702
ImmunityBio
IBRX
$7.15B
-62,150
Closed -$159K
IPG
1703
DELISTED
Interpublic Group of Companies
IPG
-17,269
Closed -$484K
IQ icon
1704
iQIYI
IQ
$1.19B
-44,150
Closed -$88.7K
IRWD icon
1705
Ironwood Pharmaceuticals
IRWD
$586M
-85,392
Closed -$378K
JWN
1706
DELISTED
Nordstrom
JWN
-59,347
Closed -$1.43M
KOS icon
1707
Kosmos Energy
KOS
$1.47B
-193,057
Closed -$660K
KROS icon
1708
Keros Therapeutics
KROS
$197M
-340
Closed -$5.38K
MRVI icon
1709
Maravai LifeSciences
MRVI
$972M
-37,150
Closed -$202K
NMRA icon
1710
Neumora Therapeutics
NMRA
$306M
-150,000
Closed -$1.59M
NOVA
1711
DELISTED
Sunnova Energy
NOVA
-91,059
Closed -$312K
NVO
1712
Novo Nordisk
NVO
$228B
-469,351
Closed -$40.4M
OLMA icon
1713
Olema Pharmaceuticals
OLMA
$977M
-18,849
Closed -$110K
PLRX icon
1714
Pliant Therapeutics
PLRX
$65M
-42,768
Closed -$563K
PLYA
1715
DELISTED
Playa Hotels & Resorts
PLYA
-129,640
Closed -$1.64M
PRA
1716
DELISTED
ProAssurance
PRA
-32,777
Closed -$521K
PRAX icon
1717
Praxis Precision Medicines
PRAX
$8.11B
-27,650
Closed -$2.13M
RDFN
1718
DELISTED
Redfin
RDFN
-79,700
Closed -$627K
RIGL icon
1719
Rigel Pharmaceuticals
RIGL
$723M
-85,878
Closed -$1.44M
SAGE
1720
DELISTED
Sage Therapeutics
SAGE
-44,021
Closed -$239K
FLNA
1721
Filana Therapeutics
FLNA
$42M
-36,496
Closed -$86.1K
SPY icon
1722
State Street SPDR S&P 500 ETF Trust
SPY
$771B
-515,457
Closed -$302M
STRL icon
1723
Sterling Infrastructure
STRL
$15.2B
-635
Closed -$107K
SVC
1724
Service Properties Trust
SVC
$1.05B
-22,855
Closed -$290K
SYRE icon
1725
Spyre Therapeutics
SYRE
$8.5B
-82,475
Closed -$1.92M

Similar funds

Ensign Peak Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Ensign Peak Advisors held 1,740 positions worth $52.3B, down 7.1% from $56.3B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 4.7%. Ensign Peak Advisors opened 31 new positions and exited 51, leaving the 1,740-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

  • Ensign Peak Advisors's largest Q1 2025 buy was iShares Russell 2000 ETF: 355,907 shares worth $71M.
  • Ensign Peak Advisors added most to FTAI Aviation in Q1 2025, an estimated $151M increase.
  • Ensign Peak Advisors's biggest Q1 2025 reduction was Thermo Fisher Scientific, cutting an estimated $156M.
  • Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q1 2025, selling an estimated $302M.
  • Ensign Peak Advisors's ten largest holdings make up 30% of its $52.3B portfolio in Q1 2025.
  • Ensign Peak Advisors opened 31 new positions and closed 51 in Q1 2025.
  • Ensign Peak Advisors's portfolio value fell 7.1% quarter-over-quarter to $52.3B.

Based on Ensign Peak Advisors's 13F filing for Q1 2025, filed 14 May 2025.